Amicus Therapeutics, Inc.
FOLD
$9.94
$0.161.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.06M | -38.10M | -29.37M | -56.11M | -104.69M |
| Total Depreciation and Amortization | 7.60M | 7.90M | 8.23M | 8.55M | 8.69M |
| Total Amortization of Deferred Charges | 2.49M | 2.41M | 2.34M | 2.26M | 2.20M |
| Total Other Non-Cash Items | 93.61M | 92.89M | 92.98M | 110.35M | 121.79M |
| Change in Net Operating Assets | -76.67M | -110.76M | -70.62M | -98.94M | -54.51M |
| Cash from Operations | 12.98M | -45.66M | 3.56M | -33.89M | -26.52M |
| Capital Expenditure | -3.29M | -3.26M | -1.95M | -3.55M | -5.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -57.05M | -21.50M | -39.00M | 2.99M | 871.00K |
| Cash from Investing | -60.33M | -24.76M | -40.96M | -560.00K | -4.13M |
| Total Debt Issued | -- | -- | -- | -- | 387.36M |
| Total Debt Repaid | -83.00K | -42.00K | -70.00K | -97.00K | -408.29M |
| Issuance of Common Stock | 2.45M | 23.07M | 23.89M | 27.24M | 57.52M |
| Repurchase of Common Stock | -14.69M | -15.84M | -17.09M | -22.03M | -22.76M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -1.59M |
| Cash from Financing | -12.32M | 7.19M | 6.73M | 5.12M | 12.23M |
| Foreign Exchange rate Adjustments | 16.71M | 12.89M | 2.60M | -4.03M | -11.04M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -42.96M | -50.34M | -28.06M | -33.36M | -29.45M |